16 research outputs found
Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease
Full text link
Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study
No full text
Image Analysis for Cystic Fibrosis: Computer-Assisted Airway Wall and Vessel Measurements from Low-Dose, Limited Scan Lung CT Images
No full text
Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
No full text
State of progress in treating cystic fibrosis respiratory disease
Get PDF<p>Abstract</p> <p>Since the discovery of the gene associated with cystic fibrosis (CF), there has been tremendous progress in the care of patients with this disease. New therapies have entered the market and are part of the standard treatment of patients with CF, and have been associated with marked improvement in survival. Now there are even more promising therapies directed at different components of the pathophysiology of this disease. In this review, our current knowledge of the pathophysiology of lung disease in patients with CF is described, along with the current treatment of CF lung disease, and the therapies in development that offer great promise to our patients.</p
